Korsana Biosciences, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 18 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: RNTX, DBVT, AMST→
From the filings
Figures
- Revenue
- $2.0Mlast 12 months
- Net income
- −$6.7Mlast 12 months
- Operating cash flow
- −$3.5Mlast 12 months
- Cash and equivalents
- $1.4Mat the last balance sheet
- Shares outstanding
- 4.3M shareson issue